chr13-103049340-G-A
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 1P and 16B. PP3BP4_StrongBP6_Very_StrongBS2
The ENST00000245312.5(SLC10A2):c.868C>T(p.Pro290Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0104 in 1,613,978 control chromosomes in the GnomAD database, including 130 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P290L) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000245312.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -15 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC10A2 | NM_000452.3 | c.868C>T | p.Pro290Ser | missense_variant | 5/6 | ENST00000245312.5 | NP_000443.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC10A2 | ENST00000245312.5 | c.868C>T | p.Pro290Ser | missense_variant | 5/6 | 1 | NM_000452.3 | ENSP00000245312 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00874 AC: 1330AN: 152164Hom.: 10 Cov.: 32
GnomAD3 exomes AF: 0.00998 AC: 2508AN: 251256Hom.: 25 AF XY: 0.0101 AC XY: 1367AN XY: 135782
GnomAD4 exome AF: 0.0106 AC: 15488AN: 1461696Hom.: 120 Cov.: 31 AF XY: 0.0105 AC XY: 7613AN XY: 727162
GnomAD4 genome AF: 0.00873 AC: 1329AN: 152282Hom.: 10 Cov.: 32 AF XY: 0.00826 AC XY: 615AN XY: 74456
ClinVar
Submissions by phenotype
not specified Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency in 1000Genomes: 22/2178=1% - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Feb 10, 2017 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2023 | SLC10A2: BS1, BS2 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at